Close
  Indian J Med Microbiol
 

Table 3: Diabetic ketoacidosis (DKA) with SGLT2 inhibitors in phase 2/3 studies

Table 3:  Diabetic  ketoacidosis (DKA)  with  SGLT2  inhibitors in phase 2/3 studies